Crossmark

Cost-effectiveness evaluation of the use of PCSK9 inhibitors

Crossref DOI link: https://doi.org/10.1016/j.endien.2021.05.003

Published Print: 2021-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Civeira, Fernando

Pedro-Botet, Juan
License Information

Text and Data Mining valid from 2021-06-01
More Information

This article is maintained by: Elsevier

Article Title: Cost-effectiveness evaluation of the use of PCSK9 inhibitors

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2021.05.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endinu.2021.05.001

Content Type: article

Copyright: © 2021 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.